In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.
about
Enhancing oral vaccine potency by targeting intestinal M cellsStructure–activity correlations of variant forms of the B pentamer ofEscherichia colitype II heat-labile enterotoxin LT-IIb with Toll-like receptor 2 bindingIdentification of novel synthetic toll-like receptor 2 agonists by high throughput screening.LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.AB toxins: a paradigm switch from deadly to desirableBotulinum neurotoxin type A induces TLR2-mediated inflammatory responses in macrophages.Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits.LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunityHeat-labile enterotoxins as adjuvants or anti-inflammatory agents.Toll-like receptor modulators: a patent review (2006-2010).Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine.Toll-like receptor agonists: a patent review (2011 - 2013).Differential capacity for complement receptor-mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte.The design of new adjuvants for mucosal immunity to Neisseria meningitidis B in nasally primed neonatal mice for adult immune response.
P2860
Q21089613-3920F5CF-7521-477D-AE61-00A1E04EF7D7Q27675134-B99ABBE0-1C6F-433B-A644-2CBC35320CDFQ33588328-03446B72-33B1-4541-98B2-7E7A6482619EQ34558281-04774341-94A6-4B9E-BEFD-01936ED9E594Q35155875-4759D881-954B-4535-901E-2397F752C44FQ35326849-7A1460D9-998C-4C7F-9590-12E2B5392751Q35571431-6F088211-B41D-4BA6-B882-0DACFEF6C345Q35840727-6D950168-1C06-45F3-A4AC-DEFBDFDB041FQ37066634-CF58C4E6-0D48-4647-B656-141534769041Q37749719-837D27A0-B60B-4873-8282-5DD70B7A0432Q37853197-97F4CDE7-A674-46B2-9EFE-EB9F215264DEQ38058640-D17F5622-E28B-4E25-BB3B-7E67797F03C2Q38103192-7E0FB9C0-301D-4A60-A845-05B343A7CE34Q38181176-12F8D582-A1C7-4396-91E3-9D25EBD2738BQ39848642-80CD80A6-993D-4E58-90DD-30E40E8A0917Q54337514-D8F616C8-2E76-496C-A087-4C81F42100B6
P2860
In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo and in vitro adjuvant ...... IIb-B5) from Escherichia coli.
@en
In vivo and in vitro adjuvant ...... pe IIb heat-labile enterotoxin
@nl
type
label
In vivo and in vitro adjuvant ...... IIb-B5) from Escherichia coli.
@en
In vivo and in vitro adjuvant ...... pe IIb heat-labile enterotoxin
@nl
prefLabel
In vivo and in vitro adjuvant ...... IIb-B5) from Escherichia coli.
@en
In vivo and in vitro adjuvant ...... pe IIb heat-labile enterotoxin
@nl
P2093
P2860
P50
P1433
P1476
In vivo and in vitro adjuvant ...... -IIb-B5) from Escherichia coli
@en
P2093
Hesham F Nawar
Kavita B Hosur
Shuang Liang
P2860
P304
P356
10.1016/J.VACCINE.2009.05.027
P407
P577
2009-05-29T00:00:00Z